Clinical Investigator
Supra Verma, MD
Horizon Therapeutics
Total Trials
1
As PI
0
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
MIXED(2)
2 unique interventions1 categories
Analytics
Trial Phases
Phase 41
Trial Status
Completed1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)
Chronic GoutUncontrolled Gout
StudydirectorStart date: 2021-01-26
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Horizon Therapeutics
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
3 similar investigators found
Qianhua Li, M.D.&Ph.D
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
1 trials
Shared therapeutic areas:
Chronic Gout
Similarity Score15%
Kathleen Giacomini, PhD
University of California, San Francisco
5 trials
Shared therapeutic areas:
Chronic Gout
Similarity Score15%
Robert Keenan, MD
Arthrosi Therapeutics, Inc.
3 trials
Shared therapeutic areas:
Uncontrolled Gout
Similarity Score15%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)
Chronic GoutUncontrolled Gout
All 1 trials loaded